Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes, Gestational | 5 | 2024 | 116 | 1.730 |
Why?
|
| Leptin | 4 | 2016 | 306 | 1.060 |
Why?
|
| Diet, High-Fat | 6 | 2022 | 247 | 1.040 |
Why?
|
| Receptors, Leptin | 3 | 2022 | 67 | 0.980 |
Why?
|
| Sugars | 2 | 2022 | 16 | 0.950 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2020 | 263 | 0.910 |
Why?
|
| Insulins | 1 | 2022 | 19 | 0.840 |
Why?
|
| Lipid Metabolism | 3 | 2020 | 476 | 0.810 |
Why?
|
| Placenta | 5 | 2022 | 561 | 0.800 |
Why?
|
| Uterus | 2 | 2024 | 798 | 0.790 |
Why?
|
| Endometriosis | 1 | 2024 | 231 | 0.740 |
Why?
|
| Endometrium | 1 | 2024 | 457 | 0.720 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 43 | 0.710 |
Why?
|
| Fetal Development | 3 | 2020 | 118 | 0.700 |
Why?
|
| Fertility | 1 | 2022 | 336 | 0.680 |
Why?
|
| Pre-Eclampsia | 3 | 2020 | 237 | 0.680 |
Why?
|
| Insulin Resistance | 2 | 2022 | 732 | 0.660 |
Why?
|
| Pregnancy | 17 | 2024 | 8130 | 0.600 |
Why?
|
| Maternal Exposure | 2 | 2016 | 154 | 0.570 |
Why?
|
| Energy Metabolism | 1 | 2020 | 997 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2016 | 235 | 0.450 |
Why?
|
| Food Deprivation | 1 | 2012 | 48 | 0.410 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 7381 | 0.400 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 35 | 0.380 |
Why?
|
| Embryo Implantation | 2 | 2024 | 289 | 0.370 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 67 | 0.370 |
Why?
|
| Adrenomedullin | 3 | 2022 | 106 | 0.360 |
Why?
|
| Mice | 15 | 2024 | 35600 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 9 | 2022 | 7100 | 0.350 |
Why?
|
| Obesity | 2 | 2020 | 2904 | 0.320 |
Why?
|
| Antioxidants | 1 | 2011 | 521 | 0.300 |
Why?
|
| Animals | 18 | 2024 | 61956 | 0.300 |
Why?
|
| Insulin | 4 | 2022 | 1483 | 0.280 |
Why?
|
| Oxidative Stress | 1 | 2011 | 1149 | 0.240 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 49 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2024 | 5728 | 0.240 |
Why?
|
| Fallopian Tubes | 1 | 2024 | 129 | 0.220 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 94 | 0.210 |
Why?
|
| Female | 19 | 2024 | 148940 | 0.200 |
Why?
|
| Parturition | 1 | 2022 | 64 | 0.200 |
Why?
|
| Progesterone | 1 | 2024 | 711 | 0.190 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 317 | 0.180 |
Why?
|
| Receptors, Complement 3b | 1 | 2020 | 20 | 0.180 |
Why?
|
| Placentation | 1 | 2020 | 61 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 1 | 2022 | 160 | 0.180 |
Why?
|
| Lipolysis | 1 | 2020 | 102 | 0.180 |
Why?
|
| Glucose | 2 | 2022 | 1218 | 0.170 |
Why?
|
| Microbiota | 1 | 2024 | 547 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 217 | 0.140 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 71 | 0.140 |
Why?
|
| Animal Feed | 1 | 2017 | 91 | 0.140 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2017 | 51 | 0.140 |
Why?
|
| Spermatogenesis | 1 | 2018 | 268 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 86 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 4223 | 0.130 |
Why?
|
| Acetylcholine | 1 | 2016 | 106 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2016 | 213 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2015 | 88 | 0.120 |
Why?
|
| Testis | 1 | 2018 | 620 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2020 | 1568 | 0.120 |
Why?
|
| Hair Color | 1 | 2012 | 20 | 0.110 |
Why?
|
| Fibrosis | 1 | 2016 | 733 | 0.110 |
Why?
|
| Genistein | 1 | 2012 | 74 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 1903 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 54 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 83 | 0.100 |
Why?
|
| Phenols | 1 | 2012 | 105 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 2115 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 699 | 0.100 |
Why?
|
| Sex Factors | 1 | 2016 | 2184 | 0.090 |
Why?
|
| Body Weight | 1 | 2015 | 1307 | 0.090 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 444 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 564 | 0.090 |
Why?
|
| Liver | 2 | 2016 | 3086 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 5002 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1963 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2020 | 5438 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2012 | 801 | 0.060 |
Why?
|
| Streptococcus | 1 | 2024 | 79 | 0.060 |
Why?
|
| Apoptosis | 1 | 2018 | 7757 | 0.060 |
Why?
|
| Streptococcus agalactiae | 1 | 2024 | 113 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2022 | 25 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2024 | 241 | 0.050 |
Why?
|
| Vagina | 1 | 2024 | 331 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 3844 | 0.050 |
Why?
|
| Complement Inactivating Agents | 1 | 2020 | 17 | 0.050 |
Why?
|
| Receptors, Complement | 1 | 2020 | 48 | 0.040 |
Why?
|
| Humans | 6 | 2024 | 270740 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 80 | 0.040 |
Why?
|
| Complement Activation | 1 | 2020 | 93 | 0.040 |
Why?
|
| Gene Expression | 2 | 2020 | 3640 | 0.040 |
Why?
|
| Perilipin-1 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2020 | 152 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2019 | 23 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2019 | 25 | 0.040 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2019 | 25 | 0.040 |
Why?
|
| Dietary Sugars | 1 | 2019 | 20 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 110 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 346 | 0.040 |
Why?
|
| Sperm Count | 1 | 2018 | 92 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 497 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4130 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 680 | 0.030 |
Why?
|
| Binding Sites | 1 | 2020 | 2255 | 0.030 |
Why?
|
| Male | 5 | 2018 | 128315 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2015 | 61 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 103 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 2825 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 1038 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 2196 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1368 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 140 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2019 | 1309 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 611 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1281 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 448 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 252 | 0.030 |
Why?
|
| Pancreas | 1 | 2016 | 744 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 794 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 1093 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3597 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3476 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 15912 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 13006 | 0.010 |
Why?
|